中文别名:
(4R)-2-[2-(二苯基膦基)苯基]-4-苯基-4,5-二氢-1,3-恶唑;(R)-(-)-2-[2-(二苯基膦)苯基]-4-苯基-2-噁唑啉;双酚F(2,3-二羟基丙醚)BFDGE-2H2O;(R)-(-)-2-[2-(二苯基膦)苯基]-4-苯基-2-唑啉;(4R)-2-[2-(二苯基膦)苯基]-4,5-二氢-4-苯基恶唑;(R)-(-)-2-[2-(二苯基膦)苯基]-4-苯基-2-噁唑啉 500MG;
英文别名:
Oxazole,2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-4-phenyl-, (4R)-;(4R)-2-[2-(diphenylphosphanyl)phenyl]-4-phenyl-4,5-dihydro-1,3-oxazole;(R)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline;diphenyl-[2-[(4R)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl]phosphane;(4R)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole;(R)-(?)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline;R(-)-2-(2-(DIPHENYLPHOSPHINO)PHENYL)-;(R)-2-(2-(Diphenylphosphino)phenyl)-4-phenyl-4,5-dihydrooxazole;(4R)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-4-phenyl-Oxazole;Oxazole, 2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-4-phenyl-, (4R)-;J-010342;CS-0086116;DTXSID20431352;(R)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline, >=97.0% (31P-NMR);(R)-2-(2-(Diphenylphosphino)phenyl)-4,5-dihydro-4-phenyloxazole;(R)-Ph-Phox;AS-72611;AKOS025294683;D74609;167171-03-1;MFCD01863025;A926741;EX-A7846X;SCHEMBL2367533;(R)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline >=97.0% (31P-NMR);DB-235145;(4R)-2-[2-(diphenylphosphino)phenyl]-4-phenyl-4,5-dihydro-1,3-oxazole;
Inchi:
1S/C27H22NOP/c1-4-12-21(13-5-1)25-20-29-27(28-25)24-18-10-11-19-26(24)30(22-14-6-2-7-15-22)23-16-8-3-9-17-23/h1-19,25H,20H2/t25-/m0/s1